These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8547212)

  • 1. Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Leor J; Goldbourt U; Behar S; Boyko V; Reicher-Reiss H; Kaplinsky E; Rabinowitz B
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):609-17. PubMed ID: 8547212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group.
    Leor J; Goldbourt U; Rabinowitz B; Reicher-Reiss H; Boyko V; Kaplinsky E; Behar S
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):723-9. PubMed ID: 8573556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are coronary patients at higher risk with digoxin therapy? An ongoing controversy.
    Reicher-Reiss H; Jonas M; Boyko V; Shotan A; Goldbourt U; Behar S
    Int J Cardiol; 1999 Feb; 68(2):137-43. PubMed ID: 10189000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bundle branch block in acute Q wave inferior wall myocardial infarction. A high risk subgroup of inferior myocardial infarction patients. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Hod H; Goldbourt U; Behar S
    Eur Heart J; 1995 Apr; 16(4):471-7. PubMed ID: 7671891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.
    Eur Heart J; 1988 Apr; 9(4):354-64. PubMed ID: 2898363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety concerns about digoxin after acute myocardial infarction.
    Spargias KS; Hall AS; Ball SG
    Lancet; 1999 Jul; 354(9176):391-2. PubMed ID: 10437870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is digoxin an independent risk factor for long-term mortality after acute myocardial infarction?
    Køber L; Torp-Pedersen C; Gadsbøll N; Hildebrandt P; Høilund-Carlsen PF
    Eur Heart J; 1994 Mar; 15(3):382-8. PubMed ID: 8013513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.
    Kornowski R; Goldbourt U; Zion M; Mandelzweig L; Kaplinsky E; Levo Y; Behar S
    Am J Cardiol; 1993 Oct; 72(12):883-8. PubMed ID: 8213543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
    Goldbourt U; Behar S; Reicher-Reiss H; Zion M; Mandelzweig L; Kaplinsky E
    Arch Intern Med; 1993 Feb; 153(3):345-53. PubMed ID: 8285927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups.
    Gottlieb S; Goldbourt U; Boyko V; Harpaz D; Mandelzweig L; Khoury Z; Stern S; Behar S
    Eur Heart J; 2000 Feb; 21(4):284-95. PubMed ID: 10653676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in mortality of male and female patients surviving acute myocardial infarction: long-term follow-up of 5,700 patients. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
    Harpaz D
    Eur J Epidemiol; 1997 Oct; 13(7):745-54. PubMed ID: 9384262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Haim M; Gottlieb S; Boyko V; Reicher-Reiss H; Hod H; Kaplinsky E; Mandelzweig L; Goldbourt U; Behar S
    Am Heart J; 1998 Aug; 136(2):245-51. PubMed ID: 9704685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.
    Volpi A; de Vita C; Franzosi MG; Geraci E; Maggioni AP; Mauri F; Negri E; Sontoro E; Tavazzi L; Tognoni G
    J Am Coll Cardiol; 1994 Sep; 24(3):608-15. PubMed ID: 8077528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Reicher-Reiss H; Behar S; Boyko V; Mandelzweig L; Kaplinsky E; Goldbourt U
    Cardiovasc Drugs Ther; 1998 May; 12(2):171-6. PubMed ID: 9652875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study Group.
    Tanne D; Goldbourt U; Zion M; Reicher-Reiss H; Kaplinsky E; Behar S
    Stroke; 1993 Oct; 24(10):1490-5. PubMed ID: 8378952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
    Neufeld HN
    Eur Heart J; 1986 Jul; 7 Suppl B():51-2. PubMed ID: 3530769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study.
    Muller JE; Turi ZG; Stone PH; Rude RE; Raabe DS; Jaffe AS; Gold HK; Gustafson N; Poole WK; Passamani E; Smith TW; Braunwald E;
    N Engl J Med; 1986 Jan; 314(5):265-71. PubMed ID: 3510391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction.
    Sarasin FP; Maschiangelo ML; Schaller MD; Héliot C; Mischler S; Gaspoz JM
    Am J Med; 1999 May; 106(5):499-505. PubMed ID: 10335720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Benderly M; Behar S; Reicher-Reiss H; Boyko V; Goldbourt U
    Am J Epidemiol; 1997 Jul; 146(2):153-60. PubMed ID: 9230777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.